Molecular biology of hepatitis C infection.
Hepatitis C infection (HCV) is an emerging epidemic. Liver specialists are managing this disease with limited scientific information about the underlying pathogenesis and treatment. The current review offers a molecular dissection of infection, a snapshot of the HCV life cycle, and emerging strategies for antiviral therapy.
Drazan
K E
KE
Liver Transplant Program, Stanford University, Palo Alto, CA, USA. kdrazan@leland.stanford.edu
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D016679:Genome, Viral; D016174:Hepacivirus / Q000235:genetics* / Q000502:physiology; D006526:Hepatitis C / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D008969:Molecular Sequence Data; D011973:Receptors, LDL / Q000502:physiology; D014779:Virus Replication
D000998:Antiviral Agents; D011973:Receptors, LDL